Prestige Consumer Healthcare PBH
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 39th percentile, 5-year average 4.7x
#1119 of 2993 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 1st percentile, 5-year average 1.9x
#1650 of 5330 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 1st percentile, 5-year average 2.8x
#2460 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.13 | – | 1.87 | 1% (cheaper than usual) | #1650 of 5330 (1 = cheapest) |
| PE | 14.26 | 9.67 | 4.71 | 39% (cheaper than usual) | #1119 of 2993 (1 = cheapest) |
| PS | 1.88 | 1.63 | 2.81 | 1% (cheaper than usual) | #2460 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on PBH.
Sign in to join the discussion.